The largest US drugstore operator Walgreens Boots Alliance has made a takeover approach to drug distributor AmerisourceBergen the Wall Street Journal reported on Monday, outlining a deal that would accelerate healthcare sector consolidation.
Walgreens is valued at $67.82 billion and AmerisourceBergen has a market capitalization of US$19.65 billion, according to WSJ.
Healthcare payers and pharmacies are responding to a shifting landscape, including changes in the US Affordable Care Act, rising drug prices and the threat of competition from online retailers such as Amazon.com.
A new deal by Walgreens would follow the US$69 billion acquisition of health insurer Aetna Inc by drugstore rival CVS Health Corp and would also reflect a move toward vertical consolidation, where members of a supply chain combine.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Turkish Antitrust Authority Approves Tofaş Takeover of Stellantis Distribution Unit
Apr 20, 2025 by
CPI
Ohio Sues United Wholesale Mortgage Over Alleged Broker Collusion
Apr 20, 2025 by
CPI
Italy Reconsiders Digital Services Tax as US Tech Pressure Mounts
Apr 20, 2025 by
CPI
Japan’s Antitrust Regulator to Warn Top Tokyo Hotels Over Pricing Information Sharing
Apr 20, 2025 by
CPI
Senate Judiciary Committee Advances Bipartisan Bills to Address Drug Pricing and Competition
Apr 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – The Airline Industry
Apr 10, 2025 by
CPI
Boosting Competition in International Aviation
Apr 10, 2025 by
Jeffrey N. Shane
Reshaping Competition Policy for the U.S. Airline Industry
Apr 10, 2025 by
Diana L. Moss
Algorithmic Collusion in the Skies: The Role of AI in Shaping Airline Competition
Apr 10, 2025 by
Qi Ge, Myongjin Kim & Nicholas Rupp
Competition in U.S. Airline Markets: Major Developments and Economic Insights
Apr 10, 2025 by
Germán Bet